# Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients

> **NCT05664906** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 40 (estimated)

## Conditions studied

- Head and Neck Neoplasms
- Oral Mucositis (Ulcerative) Due to Radiation
- Chinese Medicine Oral Rinse

## Interventions

- **DRUG:** Chinese Medicine Oral Rinse Formula-I (CMORF-I)
- **OTHER:** Standard Care
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05664906
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-31
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-11-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05664906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05664906, "Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05664906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*